-+ 0.00%
-+ 0.00%
-+ 0.00%

Aptevo Therapeutics FY2025 loss per share narrows to $87.27; cash and cash equivalents jump 148% to $22 million

Reuters·03/26/2026 12:06:59

Please log in to view news